Trial intelligence / Profile preview

Ramelteon prevention of postoperative sleep disorders in hospitalized patients with autism spectrum disorder undergoing general anesthesia

jRCT1071200030Completed

Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of ramelteon in Insomnia and sleep disorder. Primary endpoint: Incidence of non-REM / REM sleep disorder. Started Jul 2021; status: completed.

02

Drugs

ramelteon
03

Conditions

Insomniasleep disorder

Beyond the preview

Go deeper on jRCT1071200030.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1071200030.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call